Vitamin B12 Deficiency
📧 Sign up to get email alerts when something new happens for Vitamin B12 Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Early Infant Micronutrition and Development [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update investigating early infant micronutrition for development in infants with vitamin B12 deficiency.
-
FDA approval · 2022-11-15FDA Approved: CYANOCOBALAMIN — Original Application (Sagent Pharmaceuticals)
FDA approved an original-application generic cyanocobalamin (Vitamin B12) from Sagent Pharmaceuticals.
-
FDA approval · 2022-10-14FDA Approved: CYANOCOBALAMIN — Supplemental Application (Plano Pharmaceuticals Inc.)
FDA approved a supplemental application for cyanocobalamin from Plano Pharmaceuticals Inc., indicating changes to an already approved produc…
-
FDA approval · 2022-04-15FDA Approved: CYANOCOBALAMIN — Original Application (SOLA Pharmaceuticals)
FDA approved SOLA Pharmaceuticals' original application for CYANOCOBALAMIN (cyanocobalamin), a generic vitamin B12 product.
-
FDA approval · 2022-04-15FDA Approved: CYANOCOBALAMIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved Cyanocobalamin from Zydus Pharmaceuticals USA Inc. under an Original Application (ANDA214655).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Natural Versus Synthetic Vitamin B Complexes in Human [NA]
A completed clinical trial comparing natural versus synthetic vitamin B complexes; results posted in 2021.
-
FDA approval · 2020-12-08FDA Approved: CYANOCOBALAMIN — Original Application (AuroMedics Pharma LLC)
The FDA approved a generic cyanocobalamin product from AuroMedics Pharma LLC under an Original Application (ANDA213874).
-
FDA approval · 2020-10-21FDA Approved: CYANOCOBALAMIN — Supplemental Application (Somerset Therapeutics, LLC)
The FDA approved a supplemental application for cyanocobalamin from Somerset Therapeutics, LLC under an ANDA.
-
FDA approval · 2020-09-24FDA Approved: CYANOCOBALAMIN — Original Application (Plano Pharmaceuticals Inc.)
FDA approved Plano Pharmaceuticals Inc.'s original application for cyanocobalamin (vitamin B12) as a generic drug.
-
FDA approval · 2020-09-09FDA Approved: CYANOCOBALAMIN — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic cyanocobalamin product from Padagis Israel Pharmaceuticals Ltd under an original ANDA (212458).
-
CLINICAL_TRIALS research · 2020-06-11Clinical Trial Update: Vitamin Deficiencies and Suppletion in Morbid Obesity [Phase 4]
Phase 4 clinical trial investigating vitamin B12 deficiency and supplementation in individuals with morbid obesity.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia. [Phase 4]
Phase 4 trial evaluating methycobalamin for early dementia in patients with vitamin B12 deficiency and hyperhomocysteinaemia; the study is c…
-
FDA approval · 2018-12-18FDA Approved: CYANOCOBALAMIN — Original Application (Vitruvias Therapeutics)
FDA approved the original application for cyanocobalamin from Vitruvias Therapeutics, enabling a generic cyanocobalamin product to be market…
-
FDA approval · 2018-12-18FDA Approved: CYANOCOBALAMIN — Original Application (Somerset Therapeutics, LLC)
FDA approves cyanocobalamin (generic) from Somerset Therapeutics, LLC via Original Application (ANDA209429).
-
FDA approval · 2018-12-07FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)
FDA approved a supplemental application for NASCOBAL (cyanocobalamin) submitted by ENDO USA, Inc.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Homocysteine After Laparoscopic Roux-enY Gastric Bypass
This completed clinical trial evaluated changes in homocysteine levels after laparoscopic Roux-en-Y gastric bypass in people with morbid obe…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients [NA]
A completed clinical trial evaluating whether Vitamin B12 supplementation improves glycemic control in patients with Type 2 diabetes and hyp…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Oral/Intramuscular B12 to Treat Cobalamin Deficiency [NA]
Clinical trial update indicates completion of a study evaluating oral and intramuscular vitamin B12 for cobalamin deficiency.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Vitamin B12 Acceptance and Biomarker Response Study [Phase 4]
Phase 4 clinical trial update from University Hospital Basel evaluating Vitamin B12 acceptance and biomarker response in individuals with Vi…
-
FDA approval · 2016-04-25FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)
FDA approved a supplemental application for NASCOBAL (cyanocobalamin) submitted by ENDO USA, Inc.
-
FDA approval · 2015-12-11FDA Approved: CYANOCOBALAMIN — Original Application (Somerset Therapeutics, LLC)
The FDA approved an original generic application for cyanocobalamin (vitamin B12) from Somerset Therapeutics, LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin [NA]
Completed clinical trial comparing two pharmacist-led approaches to increase monitoring of vitamin B12 levels and serum creatinine in patien…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development [NA]
This completed clinical trial evaluated cobalamin (Vitamin B12) supplementation during infancy and its effects on B-vitamin status, growth, …
-
FDA label_change · 2015-06-17FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)
FDA approves a supplemental application for NASCOBAL (cyanocobalamin) from ENDO USA, Inc., likely updating labeling.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients
Clinical trial evaluating the presence of autoantibodies to gastric parietal cells in rheumatoid arthritis patients with vitamin B12 deficie…